Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Archives of Dermatological Research

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02507102PMID 8818181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphotoxin detected in the blister fluid of bullous pemphigoid patients

  2004influential reference
• Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid

  2004influential reference
• The interleukin-2 receptor in lesions and serum of bullous pemphigoid

  2004cited by this paper
• High histamine level in the blister fluid of bullous pemphigoid

  2004cited by this paper
• Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid

  2004cited by this paper
• High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid.

  1995cited by this paper
• Cytokine profile of patients with bullous pemphigoid

  1994cited by this paper
• Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.

  1993cited by this paper
• Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.

  1993influential reference
• Interleukin-10.

  1993cited by this paper
• Identification and induction of keratinocyte-derived IL-10.

  1992cited by this paper
• Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology.

  1992cited by this paper
• Functional characterization of human IL-10.

  1992cited by this paper
• IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.

  1992cited by this paper
• Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration.

  1992cited by this paper
• [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].

  1992cited by this paper
• Role of cell-mediated immune reaction in blister formation of bullous pemphigoid.

  1992influential reference
• Interleukin-6 in normal skin and psoriasis.

  1992cited by this paper
• Conversion of human interleukin‐4 into a high affinity antagonist by a single amino acid replacement.

  1992cited by this paper
• Interleukin-4: a prototypic immunoregulatory lymphokine.

  1991influential reference
• Keratinocytes as initiators of inflammation.

  1991cited by this paper
• Regulation of IL-3, IL-4 and GM-CSF genes and signal transduction by their receptors.

  1990cited by this paper
• Recombinant human cytokines stimulate neutrophil adherence to IgG autoantibody-treated epithelial basement membranes.

  1990cited by this paper
• Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.

  1989influential reference
• Subclass distribution of IgG autoantibodies in bullous pemphigoid.

  1986cited by this paper
• Deposition of the membrane attack complex of complement in bullous pemphigoid.

  1984cited by this paper
• Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.

  1982cited by this paper
• An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.

  1982cited by this paper
• Cellular events leading to blister formation in bullous pemphigoid

  1980cited by this paper
• Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

  1978influential reference
• IgE levels in sera of patients with pemphigus or bullous pemphigoid.

  1974cited by this paper
• Suction blister device for separation of viable epidermis from dermis.

  1968cited by this paper

• Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism

  2025cites this paper
• JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid

  2025cites this paper
• UNDERSTANDING THE PHYSIOLOGICAL MECHANISMS OF BULLOUS PEMPHIGOID

  2025cites this paper
• Serum interleukin‐10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

  2024cites this paper
• Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches

  2023cites this paper
• Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses

  2023cites this paper
• A life for autoimmune blistering diseases: in memoriam Detlef Zillikens

  2023cites this paper
• Bullous pemphigoid—What do we know about the most recent therapies?

  2022cites this paper
• Anti-IL-10 Antibody Humanization by SDR Grafting with Enhanced Affinity to Neutralize the Adverse Response of Interleukin-10

  2022cites this paper
• IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker

  2022cites this paper
• Innate immune activation as cofactor in pemphigus disease manifestation

  2022cites this paper
• Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders

  2022cites this paper
• Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom

  2022cites this paper
• The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases

  2022cites this paper
• Signal Integration by Translocation and Phosphorylation of PKCδ in the B Cell Alternate Pathway

  2021cites this paper
• MicroRNAs in pemphigus and pemphigoid diseases.

  2021cites this paper
• Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid

  2021cites this paper
• Targeting Type 2 Inflammation for Treatment of Bullous Pemphigoid

  2020cites this paper
• The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid

  2019cites this paper
• Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.

  2019cites this paper
• Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid

  2019cites this paper
• Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases

  2019cites this paper
• Resolution in bullous pemphigoid

  2019cites this paper
• Chapter 17 – Inflammation in Bullous Pemphigoid, a Skin Autoimmune Disease

  2018cites this paper
• Immunoglobulin E and bullous pemphigoid

  2018cites this paper
• Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis

  2017cites this paper
• Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.

  2016cites this paper
• A Systematic Review of Concomitant Bullous Pemphigoid and Psoriasis

  2016cites this paper
• IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases

  2016cites this paper
• Interleukin-10 levels in rat models of nerve damage and neuropathic pain.

  2015cites this paper
• Serum levels of hypersensitive-C-reactive protein in moderate and severe acne

  2015cites this paper
• A network map of Interleukin-10 signaling pathway

  2015cites this paper
• IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?

  2015cites this paper
• Recirculation of innate lymphocyte subsets in the skin

  2014cites this paper
• Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes

  2014cites this paper
• Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction.

  2013cites this paper
• The Allosteric CXCR1/2 Inhibitor DF2156A Improves Experimental Epidermolysis Bullosa Acquisita

  2013cites this paper
• Pemphigoid diseases: Pathogenesis, diagnosis, and treatment

  2012cites this paper
• Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models

  2012cites this paper
• Bullous Pemphigoid

  2012cites this paper
• Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL‐8

  2012cites this paper
• Complement in skin diseases.

  2011cites this paper
• This information is current as Autoantibodies in Bullous Pemphigoid FcR-Independent Effects of IgE and IgG DeGueme

  2011cites this paper
• Lesional Th17 cells and regulatory T cells in bullous pemphigoid

  2011cites this paper
• Differential functions of Interleukin-10 derived from different cell types in the regulation of immune responses

  2011cites this paper
• FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid

  2011cites this paper
• Autoantibodies in Bullous Pemphigoid FcR-Independent Effects of IgE and IgG

  2011cites this paper
• The role of regulatory T cells in the pathogenesis of some bullous skin diseases

  2011cites this paper
• Interleukin-17 levels in rat models of nerve damage and neuropathic pain.

  2011cites this paper
• Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity‐associated cytokine, osteopontin

  2009cites this paper
• Autoimmunity in bullous pemphigoid.

  2009cites this paper
• CCL18 is expressed in patients with bullous pemphigoid and parallels disease course

  2009cites this paper
• Experimental animal models of bullous pemphigoid.

  2009cites this paper
• Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?

  2009cites this paper
• Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes.

  2009cites this paper
• Expression of cytokines and chemokines in bullous pemphigoid

  2009cites this paper
• Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.

  2008cites this paper
• Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

  2008cites this paper
• Six Years Follow-up of the Levels of TNF-α and IL-6 in Patients with Complex Regional Pain Syndrome Type 1

  2008cites this paper
• Macrophage migration inhibitory factor (MIF) in bullous pemphigoid.

  2008cites this paper
• Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid

  2007cites this paper
• The Pathophysiology of Bullous Pemphigoid

  2007cites this paper
• Immunohistological analysis of immune cells in blistering skin lesions

  2007cites this paper
• Sensitive to Rottlerin, and Depends on Lyn Parallel with the Classical Pathway, Is Pathway for BCR Signaling Operates in Cross-Talk: The IL-4-Induced Alternate Cutting Edge: B Cell Receptor (BCR)

  2007cites this paper
• Multiplex Bead Array Assay for Detection of 25 Soluble Cytokines in Blister Fluid of Patients with Complex Regional Pain Syndrome Type 1

  2006cites this paper
• Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines.

  2006cites this paper
• Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE.

  2004cites this paper
• The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.

  2004cites this paper
• Suction Blisters and Microdialysis

  2004cites this paper
• Elevated expression and release of tissue‐type, but not urokinase‐type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes

  2004cites this paper
• Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants.

  2004cites this paper
• Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid.

  2003cites this paper
• Interleukin-10 concentration determined by sandwich enzyme-linked immunosorbent assay is unrepresentative of bioactivity in murine blood.

  2003cites this paper
• Cytokines and chemokines in human autoimmune skin disorders.

  2003cites this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cites this paper
• Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.

  2002cites this paper
• IL-4, IL-5, TGF-beta1 and IFN-gamma mRNAs detected by a new in situ amplification system in cicatricial pemphigoid.

  2002cites this paper
• Serum Eosinophil Cationic Protein, Myeloperoxidase, Tryptase, Eotaxin and Th2-Like Cytokines in Dermatitis herpetiformis

  2002cites this paper
• Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.

  2001cites this paper
• Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.

  2000cites this paper
• Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to.

  2000cites this paper
• Immune Modulation in Pemphigus Vulgaris: Role of CD28 and IL-101

  2000cites this paper
• Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.

  2000cites this paper
• High levels of interleukin‐8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T‐cell activities

  2000cites this paper
• IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.

  2000cites this paper
• Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity.

  1999cites this paper
• Acquired skin disease of hemidesmosomes.

  1999cites this paper
• Plasmapheresis treatment for bullous pemphigoid induces marked reduction of the serum IL-6 level rather than the titre of circulating autoantibodies.

  1999cites this paper
• Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use

  1999cites this paper
• Blister fluid cytokines in cutaneous inflammatory bullous disorders.

  1999cites this paper
• IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity

  1998cites this paper
• Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity

  1998cites this paper
• [Physiopathology of autoimmune bullous dermatoses of the basement membrane].

  1998cites this paper
• Decreased Interleukin‐7 and transforming growth factor‐beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid: Opposite behavior of TNF‐alpha, Interleukin‐4 and Interleukin‐10

  1998cites this paper
• Correspondence. Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters

  1998cites this paper
• Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.

  1998cites this paper
• Interleukin-10: biology, role in inflammation and autoimmunity.

  1997cites this paper
• T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30)

  1997cites this paper